A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes (Q34421851)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes |
scientific article |
Statements
1 reference
A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes (English)
1 reference
Kevan C Herold
1 reference
Stephen E Gitelman
1 reference
Umesh Masharani
1 reference
William Hagopian
1 reference
Brygida Bisikirska
1 reference
David Donaldson
1 reference
Kristina Rother
1 reference
Beverly Diamond
1 reference
David M Harlan
1 reference
Jeffrey A Bluestone
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference